As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Marex Group plc, Hudson Bay Capital Management LP, Nomura Holdings Inc., Man Group plc, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Bank of America Corp DE, Jane Street Group LLC, Tennessee Valley Asset Management Partners, Volterra Technologies LP, Squarepoint Ops LLC, Kopernik Global Investors LLC, Alphadyne Asset Management LP, Diadema Partners LP, Dymon Asia Capital Singapore PTE. LTD., Qube Research & Technologies Ltd, Capula Management Ltd, Marshall Wace LLP, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Delta Accumulation LLC, Capital Fund Management S.A., DLD Asset Management LP, All Terrain Financial Advisors LLC, Jefferies Financial Group Inc., Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Persistent Asset Partners Ltd, Creative Planning, Garda Capital Partners LP, Savant Capital LLC, Mirae Asset Securities USA Inc., Wolverine Asset Management LLC, Insight Advisors LLC PA, Allianz Asset Management GmbH, Twin Tree Management LP, Prime Capital Investment Advisors LLC, and CenterStar Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.